Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Common Equity: 2009-2025

Historic Common Equity for Rockwell Medical (RMTI) over the last 15 years, with Sep 2025 value amounting to $37.0 million.

  • Rockwell Medical's Common Equity rose 27.06% to $37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 27.06%. This contributed to the annual value of $32.6 million for FY2024, which is 53.05% up from last year.
  • Rockwell Medical's Common Equity amounted to $37.0 million in Q3 2025, which was up 21.74% from $30.4 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Common Equity ranged from a high of $37.0 million in Q3 2025 and a low of -$4.8 million during Q1 2022.
  • Over the past 3 years, Rockwell Medical's median Common Equity value was $23.5 million (recorded in 2024), while the average stood at $24.5 million.
  • Over the last 5 years, Rockwell Medical's Common Equity had its largest YoY gain of 456.45% in 2022, and its largest YoY loss of 118.35% in 2022.
  • Quarterly analysis of 5 years shows Rockwell Medical's Common Equity stood at $2.5 million in 2021, then spiked by 456.45% to $14.1 million in 2022, then surged by 50.94% to $21.3 million in 2023, then skyrocketed by 53.05% to $32.6 million in 2024, then climbed by 27.06% to $37.0 million in 2025.
  • Its Common Equity was $37.0 million in Q3 2025, compared to $30.4 million in Q2 2025 and $31.5 million in Q1 2025.